Skip to content
Peptigraph home

Is IGF-1 LR3 Legal? FDA, Compounding and WADA Status

IGF-1 LR3's FDA status, compounding rules and anti-doping status, with a dated timeline of every change we track.

Medical review pendingIGF-1 analogUpdated
FDA status
Not approved
research chemical
PCAC vote
Not reviewed
not on the Jul 2026 PCAC agenda
WADA
Prohibited (S2.3)
In and out of competition
Not legal adviceStatus reflects public FDA and WADA records on the date shown. Rules differ by country and state.

Current status

Not FDA approved · research chemical

No. IGF-1 LR3 is not FDA approved for any use.

IGF-1 LR3: regulatory status by country
CountryStatusSource
United StatesNo approved product foundNo FDA-approved product found: Drugs@FDA (openFDA) search for active ingredient "IGF-1 LR3" returned no matches on 2 Oct 2026.api.fda.govchecked 2 Oct 2026

Timeline

No FDA, advisory-committee or WADA action specific to IGF-1 LR3 found in our records (checked 2 Oct 2026).
Every peptide on the FDA tracker

Compounding and research-use sellers

  • Category 2 is the FDA's list of bulk substances it flagged as raising significant safety concerns. Compounding pharmacies are not expected to compound from them while they are on it.
  • The Pharmacy Compounding Advisory Committee (PCAC) advises the FDA on which substances belong on the 503A bulks list that pharmacies may compound from. Its votes are advice; the FDA decides.
  • "Research use only" products are sold outside these rules and are not checked by the FDA for identity, purity or dose.

Sport and drug testing

Prohibited by WADA (S2.3)

IGF-1 and its analogues (LR3 is an IGF-1 analogue) are prohibited in S2.3, at all times.

Outside the US

Rules differ by country. What each regulator's own records show, with the date we checked:

IGF-1 LR3: regulatory status by country
CountryStatusSource
United KingdomNo approved product foundNo approved product found in an emc (UK SmPC compendium) search for "IGF-1 LR3" on 2 Oct 2026.medicines.org.ukchecked 2 Oct 2026
CanadaNo approved product foundNo product found in a Health Canada Drug Product Database search for ingredient "IGF-1 LR3" on 2 Oct 2026.health-products.canada.cachecked 2 Oct 2026
AustraliaNo approved product foundNo approved product found in an ARTG search for "IGF-1 LR3" on 2 Oct 2026.tga.gov.auchecked 2 Oct 2026
European UnionNo centrally authorised EU medicine foundEMA medicines list, searched 2 Oct 2026ema.europa.euchecked 2 Oct 2026

What regulator databases show for IGF-1 LR3

The openFDA Drugs@FDA search for IGF-1 LR3 as an active ingredient found no application.[2]

Health Canada's drug product database returned no active-ingredient records for IGF-1 LR3.[4]

The Australian Register of Therapeutic Goods search for IGF-1 LR3 had no matching results.[5]

The UK emc search for IGF-1 LR3 returned no search results.[3]

How a review frames its status

A narrative review says there is no regulatory approval for physique- or performance-related indications, with product composition, dose and stacking uncertain in unregulated supply chains.[7]

The same review lists IGF-1 LR3 among the IGF-1 analogues that people encounter through online self-administration.[7]

Common questions

Is IGF-1 LR3 FDA approved?

The cached Drugs@FDA lookup for IGF-1 LR3 returned no matches.[2]

Is IGF-1 LR3 legal to buy?

It is not an approved drug. Online sellers label it "for research use only, not for human use"; the FDA sent warning letters to five such sellers on 24 Aug 2026. Whether a pharmacy may compound it depends on its FDA bulk-substance status. Rules differ by country.

Is IGF-1 LR3 banned by WADA?

Yes. Prohibited by WADA (S2.3), in and out of competition.

Is IGF-1 LR3 legal?

No application, product or register entry for IGF-1 LR3 appears in the cached FDA, Health Canada, Australian or UK searches.[2]

More on IGF-1 LR3

Sources

  1. 1World Anti-Doping Code International Standard Prohibited List 2026World Anti-Doping Agency · 2026wada-ama.orgAccessed 2 Oct 2026
  2. 2United States: No FDA-approved product found: Drugs@FDA (openFDA) search for active ingredient "IGF-1 LR3" returned no matches on 2 Oct 2026.U.S. Food and Drug Administration · 2026api.fda.govAccessed 2 Oct 2026
  3. 3United Kingdom: No approved product found in an emc (UK SmPC compendium) search for "IGF-1 LR3" on 2 Oct 2026.Electronic Medicines Compendium (UK) · 2026medicines.org.ukAccessed 2 Oct 2026
  4. 4Canada: No product found in a Health Canada Drug Product Database search for ingredient "IGF-1 LR3" on 2 Oct 2026.Health Canada · 2026health-products.canada.caAccessed 2 Oct 2026
  5. 5Australia: No approved product found in an ARTG search for "IGF-1 LR3" on 2 Oct 2026.Therapeutic Goods Administration (Australia) · 2026tga.gov.auAccessed 2 Oct 2026
  6. 6EMA medicines export (centrally authorised medicines) (searched 2 Oct 2026)European Medicines Agency · 2026ema.europa.euAccessed 2 Oct 2026
  7. 7The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration.Frontiers in endocrinology · 2026PMID 42395176Accessed 2 Oct 2026

Found an error? Report a correction.